Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Study Identifier
M02-555
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Bipolar Disorder
  • Study Drug
  • divalproex sodium
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    10 - 17 Years

    Protocol Summary

    To determine if long-term treatment, up to 6 months, with Depakote ER is safe and effective

    in the treatment of bipolar I disorder in children and adolescents.

    Study Locations

    Location
    Status
    Location
    Global Medical Information-Abbott
    North Chicago, Illinois, United States, 60064
    Status
    Not applicable